Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio
Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background
RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio.
Immuno-oncology is a leading research priority because it uses the body s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role because they use standard inbred mice that have a competent immune system, which is required to evaluate immune-modulating therapies. These models are engrafted with mouse tumors derived from the same strain background; this genetic similarity between tumor and host prevents the host from rejecting the tumor.
Greenwich Historical Society and Historic Properties of Greenwich Strike Partnership to Permanently Protect Town’s Fast Disappearing Architectural Heritage Written by Laura McCormick
Alliance Kicks Off with Seminar on Economic Benefits of Historic Property Protection
Permanent protection of Greenwich’s historic homes is the driver of an alliance between the Historical Society and the recently formed Historic Properties of Greenwich (HPG). With the escalation in homes being demolished for more contemporary structures, the need for protecting Greenwich’s classic New England heritage is greater than ever. Since 2002, there have been 1,896 residential demolition permits issued in Greenwich, for an annual average of 105. If this rate continues, Greenwich will forever lose its distinctive charm.